Temat: "Neoplasms" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy.
Autorzy :: Giesen N; Department of Haematology and Oncology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany. Electronic address: .
Sprute R; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Center for Integrated Oncology (CIO ABCD), German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany; University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Rüthrich M; Department of Haematology and Medical Oncology, Clinic for Internal Medicine II, University Hospital Jena, Jena, Germany; Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.
Khodamoradi Y; Department of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, Frankfurt Am Main, Germany.
Mellinghoff SC; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Center for Integrated Oncology (CIO ABCD), German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany; University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; Division of Infectious Diseases, 1st Department of Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
Beutel G; Department for Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; Working Party Intensive Care in Haematologic and Oncologic Patients (iCHOP) of the German Society of Haematology and Medical Oncology (DGHO).
Lueck C; Department for Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; Working Party Intensive Care in Haematologic and Oncologic Patients (iCHOP) of the German Society of Haematology and Medical Oncology (DGHO).
Koldehoff M; Working Party Intensive Care in Haematologic and Oncologic Patients (iCHOP) of the German Society of Haematology and Medical Oncology (DGHO); Department of Bone Marrow Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Hentrich M; Department of Medicine III - Haematology/Oncology, Red Cross Hospital, Munich, Germany.
Sandherr M; Specialist Clinic for Haematology and Oncology, Medical Care Center Penzberg, Penzberg, Germany.
von Bergwelt-Baildon M; Working Party Intensive Care in Haematologic and Oncologic Patients (iCHOP) of the German Society of Haematology and Medical Oncology (DGHO); Department of Internal Medicine III, LMU University Hospital, DKTK Partner Site Munich, BZKF Partner Site Munich, CCC-Munich, Munich, Germany.
Wolf HH; Department of Haematology, Oncology and Haemostaseology, Internal Medicine III, Südharzklinikum, Nordhausen, Germany.
Hirsch HH; Transplantation & Clinical Virology, Department Biomedicine (Haus Petersplatz), University of Basel, Basel, Switzerland; Clinical Virology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland; Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Wörmann B; Division of Haematology, Oncology and Tumour Immunology, Department of Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Cornely OA; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Center for Integrated Oncology (CIO ABCD), German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany; University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Köhler P; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Center for Integrated Oncology (CIO ABCD), German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany; University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Schalk E; Working Party Intensive Care in Haematologic and Oncologic Patients (iCHOP) of the German Society of Haematology and Medical Oncology (DGHO); Department of Haematology and Oncology, Medical Center, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
von Lilienfeld-Toal M; Department of Haematology and Medical Oncology, Clinic for Internal Medicine II, University Hospital Jena, Jena, Germany; Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.; Pokaż więcej
Corporate Authors :: COVID-19 guideline panel of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Źródło :: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Apr; Vol. 147, pp. 154-160. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :: Journal Article; Practice Guideline
MeSH Terms :: COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/therapy
COVID-19*/virology
Neoplasms*/diagnosis
Neoplasms*/epidemiology
Neoplasms*/therapy
Neoplasms*/virology
COVID-19 Testing/*standards
COVID-19 Vaccines/*therapeutic use
SARS-CoV-2/*physiology
Virus Shedding/*physiology
Antiviral Agents/therapeutic use ; COVID-19 Testing/methods ; Evidence-Based Medicine/standards ; Evidence-Based Medicine/statistics & numerical data ; Germany/epidemiology ; Hematologic Neoplasms/diagnosis ; Hematologic Neoplasms/epidemiology ; Hematologic Neoplasms/therapy ; Hematologic Neoplasms/virology ; Hematology/organization & administration ; Hematology/standards ; Humans ; Immunization, Passive/methods ; Immunization, Passive/standards ; Infectious Disease Medicine/organization & administration ; Infectious Disease Medicine/standards ; Medical Oncology/organization & administration ; Medical Oncology/standards ; SARS-CoV-2/immunology ; Societies, Medical/standards ; Vaccination/methods ; Vaccination/standards
SCR Protocol :: COVID-19 serotherapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Having gastroesophageal cancer is associated with increased risk of severe COVID-19-related events in patients with digestive tract cancer: A multicenter, retrospective, cohort study.
Autorzy :: Liu C; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Song K; Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hu Q; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
Hu C; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Yue J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Song Q; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.; Pokaż więcej
Źródło :: International journal of cancer [Int J Cancer] 2021 Apr 01; Vol. 148 (7), pp. 1789-1793. Date of Electronic Publication: 2020 Dec 29.
Typ publikacji :: Letter; Multicenter Study
MeSH Terms :: Esophageal Neoplasms*
Stomach Neoplasms*
COVID-19/*complications
COVID-19/mortality ; Cohort Studies ; Gastrointestinal Neoplasms ; Humans ; Retrospective Studies ; SARS-CoV-2
: Raport

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: COVID-19-Related Ethics Consultations at a Cancer Center in New York City: A Content Review of Ethics Consultations During the Early Stages of the Pandemic.
Autorzy :: Friedman DN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Pediatrics, Weill Cornell Medical College, New York, NY.; Ethics Committee, Memorial Sloan Kettering Cancer Center, New York, NY.
Blackler L; Ethics Committee, Memorial Sloan Kettering Cancer Center, New York, NY.
Alici Y; Ethics Committee, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY.
Scharf AE; Ethics Committee, Memorial Sloan Kettering Cancer Center, New York, NY.
Chin M; Ethics Committee, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY.
Chawla S; Ethics Committee, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Anesthesiology, Pain, and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Anesthesiology, Weill Cornell Medical College, New York, NY.
James MC; Ethics Committee, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY.
Voigt LP; Ethics Committee, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Anesthesiology, Pain, and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Anesthesiology, Weill Cornell Medical College, New York, NY.; Pokaż więcej
Źródło :: JCO oncology practice [JCO Oncol Pract] 2021 Mar; Vol. 17 (3), pp. e369-e376. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
Cancer Care Facilities*
Neoplasms*
Ethics Consultation/*trends
Resuscitation Orders/*ethics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Renal Cell ; Cardiopulmonary Resuscitation/ethics ; Child ; Decision Making ; Ethics Committees, Clinical ; Female ; Health Care Rationing/ethics ; Hematologic Neoplasms ; Humans ; Intensive Care Units ; Intubation, Intratracheal/ethics ; Kidney Neoplasms ; Lung Neoplasms ; Male ; Medical Futility ; Mental Competency ; Middle Aged ; Multiple Myeloma ; New York City ; Occupational Health/ethics ; Patients' Rooms ; Personal Autonomy ; Proxy ; SARS-CoV-2 ; Sarcoma ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: [Progress in conversion therapy for stage IV gastric cancer].
Autorzy :: Liang H; Department of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Centerfor Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.; Pokaż więcej
Źródło :: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery [Zhonghua Wei Chang Wai Ke Za Zhi] 2021 Feb 25; Vol. 24 (2), pp. 107-111.
Typ publikacji :: Journal Article
MeSH Terms :: Adenocarcinoma*/drug therapy
Adenocarcinoma*/mortality
Adenocarcinoma*/pathology
Adenocarcinoma*/surgery
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/mortality
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Peritoneal Neoplasms/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; China ; Combined Modality Therapy ; Esophagogastric Junction ; Gastrectomy ; Humans ; Hyperthermic Intraperitoneal Chemotherapy ; Infusions, Parenteral ; Neoadjuvant Therapy ; Neoplasm Staging ; Peritoneal Neoplasms/secondary
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Acute complicated diverticulitis is associated with an increased advanced neoplasia diagnosis rate: A retrospective study on 1852 patients.
Autorzy :: Abu Baker F; Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel, Affiliated to the Technion Faculty of Medicine, Haifa, Israel.
Ganayem M; Department of internal medicine, Hillel Yaffe Medical Center, Hadera, Israel, Affiliated to the Technion Faculty of Medicine, Haifa, Israel.
Mari A; Department of Gastroenterology, Nazareth EMMS Hospital, Affiliated with the Faculty of Medicine, Bar Illan University.
Taher R; Department of internal medicine, Hillel Yaffe Medical Center, Hadera, Israel, Affiliated to the Technion Faculty of Medicine, Haifa, Israel.
Suki M; Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel, Affiliated to the Technion Faculty of Medicine, Haifa, Israel.
Kopelman Y; Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel, Affiliated to the Technion Faculty of Medicine, Haifa, Israel.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2021 Feb 05; Vol. 100 (5), pp. e24271.
Typ publikacji :: Journal Article
MeSH Terms :: Colonoscopy*/methods
Colonoscopy*/statistics & numerical data
Diverticulitis, Colonic*/complications
Diverticulitis, Colonic*/epidemiology
Early Detection of Cancer*/methods
Early Detection of Cancer*/statistics & numerical data
Neoplasms*/diagnostic imaging
Neoplasms*/pathology
Symptom Flare Up*
Colorectal Neoplasms/*diagnosis
Colorectal Neoplasms/epidemiology ; Correlation of Data ; Female ; Humans ; Israel/epidemiology ; Male ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Tomography, X-Ray Computed/methods ; Tomography, X-Ray Computed/statistics & numerical data
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Proliferating trichilemmal tumour of the eyelid in a 7-year-old girl.
Autorzy :: Bryan A; LSU School of Medicine-Shreveport, LSU Health Shreveport, Shreveport, Louisiana, USA.
Kurian S; Otolaryngology Head and Neck Surgery, LSU Health Shreveport, Shreveport, Louisiana, USA.
Li Y; Pathology, LSU Health Shreveport, Shreveport, Louisiana, USA.
Bundrick P; Otolaryngology Head and Neck Surgery, LSU Health Shreveport, Shreveport, Louisiana, USA .; Pokaż więcej
Źródło :: BMJ case reports [BMJ Case Rep] 2021 Feb 04; Vol. 14 (2). Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Neoplasms, Adnexal and Skin Appendage*/pathology
Neoplasms, Adnexal and Skin Appendage*/surgery
Eyelid Neoplasms/*surgery
Child ; Eyelid Neoplasms/pathology ; Female ; Humans ; Neuroimaging
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: [Spinal tumors].
Autorzy :: Alektoroff K; Klinik für Diagnostische und Interventionelle Neuroradiologie, Klinikum Bremen-Mitte/Bremen-Ost, 28205, Bremen, Deutschland. .
Moulopoulos LA; Zentrum für Radiologie, Nationale und Kapodistrias-Universität Athen, Aretaieion Klinikum, Athen, Griechenland.
Papanagiotou P; Klinik für Diagnostische und Interventionelle Neuroradiologie, Klinikum Bremen-Mitte/Bremen-Ost, 28205, Bremen, Deutschland.; Zentrum für Radiologie, Nationale und Kapodistrias-Universität Athen, Aretaieion Klinikum, Athen, Griechenland.; Pokaż więcej
Transliterated Title :: Spinale Tumoren.
Źródło :: Der Radiologe [Radiologe] 2021 Mar; Vol. 61 (3), pp. 267-274. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Spinal Neoplasms*/diagnostic imaging
Ependymoma ; Humans ; Magnetic Resonance Imaging ; Meningeal Neoplasms ; Meningioma
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: [A Long Term Survival Case of Gastric Cancer with Peritoneal Dissemination Responding to Intraperitoneal Chemotherapy].
Autorzy :: Naruse T; Dept. of First Surgery, University of Fukui.
Hirono Y
Kurebayashi H
Katayama H
Sawai K
Morikawa M
Koneri K
Tamaki M
Murakami M
Goi T; Pokaż więcej
Źródło :: Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2020 Aug; Vol. 47 (8), pp. 1254-1257.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Stomach Neoplasms*
Peritoneal Neoplasms/*secondary
Adult ; Antineoplastic Combined Chemotherapy Protocols ; Drug Combinations ; Female ; Gastrectomy ; Humans ; Neoplasm Recurrence, Local ; Ovarian Neoplasms ; Oxonic Acid ; Tegafur
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Reconstruction using a frozen autograft for a skull and humeral lesion of synchronous multicentric osteosarcoma after undergoing successful neoadjuvant chemotherapy: a case report and review of the literature.
Autorzy :: Araki Y; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Hayashi K; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Yamamoto N; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan. .
Takeuchi A; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Miwa S; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Igarashi K; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Higuchi T; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Abe K; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Taniguchi Y; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Yonezawa H; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Morinaga S; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Asano Y; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
Nojima T; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.; Department of Pathology, Kanazawa University, Kanazawa, Japan.
Tsuchiya H; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.; Pokaż więcej
Źródło :: BMC surgery [BMC Surg] 2021 Jan 22; Vol. 21 (1), pp. 56. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :: Case Reports; Journal Article; Review
MeSH Terms :: Bone Neoplasms*/diagnostic imaging
Bone Neoplasms*/drug therapy
Bone Neoplasms*/surgery
Cryotherapy*/methods
Humerus*/diagnostic imaging
Humerus*/surgery
Humerus*/transplantation
Neoplasms, Multiple Primary*/diagnostic imaging
Neoplasms, Multiple Primary*/drug therapy
Neoplasms, Multiple Primary*/surgery
Occipital Bone*/diagnostic imaging
Occipital Bone*/surgery
Occipital Bone*/transplantation
Osteosarcoma*/diagnostic imaging
Osteosarcoma*/drug therapy
Osteosarcoma*/surgery
Adolescent ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Autografts ; Cisplatin/administration & dosage ; Clinical Protocols ; Combined Modality Therapy ; Doxorubicin/administration & dosage ; Female ; Femoral Neoplasms/diagnostic imaging ; Femoral Neoplasms/drug therapy ; Femoral Neoplasms/surgery ; Humans ; Iodine/therapeutic use ; Neoadjuvant Therapy ; Nitrogen/therapeutic use ; Reconstructive Surgical Procedures/methods ; Saline Solution/therapeutic use ; Skull Neoplasms/diagnostic imaging ; Skull Neoplasms/drug therapy ; Skull Neoplasms/surgery ; Transplantation, Autologous/methods
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: [Combination of intraductal papillary mucinous neoplasm with other cystic pancreatic tumors].
Autorzy :: Panteleev VI; Vishnevsky Centre of surgery, Moscow, Russia.
Kaldarov AR; Vishnevsky Centre of surgery, Moscow, Russia.
Gorin DS; Vishnevsky Centre of surgery, Moscow, Russia.
Kriger AG; Vishnevsky Centre of surgery, Moscow, Russia.; Pokaż więcej
Transliterated Title :: Sochetanie vnutriprotokovoi papillyarnoi mutsinoznoi opukholi s drugimi kistoznymi opukholyami podzheludochnoi zhelezy.
Źródło :: Khirurgiia [Khirurgiia (Mosk)] 2021 (2), pp. 80-83.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Carcinoma, Pancreatic Ductal*/diagnosis
Carcinoma, Pancreatic Ductal*/surgery
Neoplasms, Cystic, Mucinous, and Serous*/diagnosis
Neoplasms, Cystic, Mucinous, and Serous*/surgery
Pancreatic Intraductal Neoplasms*/diagnosis
Pancreatic Intraductal Neoplasms*/surgery
Pancreas/*pathology
Cystadenoma, Mucinous/diagnosis ; Cystadenoma, Mucinous/surgery ; Humans ; Pancreas/surgery ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/surgery
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Autorzy :: Bian X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, 310003, Hangzhou, People's Republic of China.; Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, People's Republic of China.
He X; Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University Medical School, Hangzhou, 310016, People's Republic of China.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77, Stockholm, Sweden.
Yang L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, 310003, Hangzhou, People's Republic of China.; Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, People's Republic of China.
Wu W; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, 310003, Hangzhou, People's Republic of China.; Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, People's Republic of China.
Li L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, 310003, Hangzhou, People's Republic of China. .; Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, People's Republic of China. .; Pokaż więcej
Źródło :: Digestive diseases and sciences [Dig Dis Sci] 2020 Jul; Vol. 65 (7), pp. 2140-2147. Date of Electronic Publication: 2019 Oct 30.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Gastrointestinal Neoplasms*
Prostatic Neoplasms*
Urogenital Neoplasms*
Carcinoma, Hepatocellular/*therapy
Liver Neoplasms/*therapy
Neoplasms, Second Primary/*therapy
Aged ; Breast Neoplasms ; Cancer Survivors ; Carcinoma, Hepatocellular/mortality ; Female ; Hematologic Neoplasms ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/mortality ; Lung Neoplasms ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Neoplasms, Second Primary/mortality ; Prognosis ; Proportional Hazards Models ; SEER Program ; Survival Rate ; Tumor Burden
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Neck subcutaneous nodule as first metastasis from broad ligament leiomyosarcoma: a case report and review of literature.
Autorzy :: Cazzato F; Department of Medical, Oral and Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Via dei Vestini, 66100, Chieti, Italy.
D'Ercole A; Surgical Pathology Unit, Santissima Annunziata Hospital, Chieti, Italy.
De Luca G; Clinical Pathology Unit, Giuseppe Mazzini Hospital, Teramo, Italy.
Aiello FB; Department of Medicine and Aging Sciences, University G. D'Annunzio, Chieti-Pescara, Chieti, Italy.
Croce A; Department of Medical, Oral and Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Via dei Vestini, 66100, Chieti, Italy. .; Pokaż więcej
Źródło :: BMC surgery [BMC Surg] 2020 Nov 25; Vol. 20 (1), pp. 297. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :: Case Reports; Journal Article; Review
MeSH Terms :: Broad Ligament*/pathology
Genital Neoplasms, Female*/pathology
Genital Neoplasms, Female*/surgery
Head and Neck Neoplasms*/secondary
Head and Neck Neoplasms*/surgery
Leiomyosarcoma*/secondary
Leiomyosarcoma*/surgery
Adnexal Diseases/*pathology
Antineoplastic Agents/therapeutic use ; Echocardiography ; Female ; Heart Neoplasms/complications ; Heart Neoplasms/diagnostic imaging ; Heart Neoplasms/drug therapy ; Heart Neoplasms/secondary ; Humans ; Middle Aged ; Tachycardia/etiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Successful emergency endovascular aortic repair for intratumoral hemorrhage in extensive retroperitoneal mass of testicular origin.
Autorzy :: Hulova S; Department of Oncology, Central Military Hospital SNP Ruzomberok, Ruzomberok, Slovak Republic. .; 2nd Department of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Klenova 1, 833 10, Bratislava, Slovak Republic. .
Aziri R; Department of Surgical Oncology, Slovak Medical University, Bratislava, Slovak Republic.; National Cancer Institute, Bratislava, Slovak Republic.
Vulev I; Center of Interventional Neuroradiology and Endovascular Treatment, Bratislava, Slovakia.
Palacka P; 2nd Department of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Klenova 1, 833 10, Bratislava, Slovak Republic.; National Cancer Institute, Bratislava, Slovak Republic.
Kolnikova G; Department of Pathology, Slovak Medical University, Bratislava, Slovak Republic.; National Cancer Institute, Bratislava, Slovak Republic.
Rejlekova K; 2nd Department of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Klenova 1, 833 10, Bratislava, Slovak Republic.; National Cancer Institute, Bratislava, Slovak Republic.
Chovanec M; 2nd Department of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Klenova 1, 833 10, Bratislava, Slovak Republic.; National Cancer Institute, Bratislava, Slovak Republic.
Mardiak J; 2nd Department of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Klenova 1, 833 10, Bratislava, Slovak Republic.; National Cancer Institute, Bratislava, Slovak Republic.
Pindak D; Department of Surgical Oncology, Slovak Medical University, Bratislava, Slovak Republic.; National Cancer Institute, Bratislava, Slovak Republic.
Mego M; 2nd Department of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Klenova 1, 833 10, Bratislava, Slovak Republic.; National Cancer Institute, Bratislava, Slovak Republic.; Pokaż więcej
Źródło :: BMC surgery [BMC Surg] 2020 Nov 07; Vol. 20 (1), pp. 272. Date of Electronic Publication: 2020 Nov 07.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Neoplasms, Germ Cell and Embryonal*/diagnostic imaging
Neoplasms, Germ Cell and Embryonal*/drug therapy
Neoplasms, Germ Cell and Embryonal*/secondary
Neoplasms, Germ Cell and Embryonal*/surgery
Retroperitoneal Neoplasms*/diagnostic imaging
Retroperitoneal Neoplasms*/drug therapy
Retroperitoneal Neoplasms*/secondary
Retroperitoneal Neoplasms*/surgery
Testicular Neoplasms*/diagnostic imaging
Testicular Neoplasms*/drug therapy
Testicular Neoplasms*/pathology
Testicular Neoplasms*/surgery
Aortic Rupture/*surgery
Endovascular Procedures/*methods
Hemorrhage/*surgery
Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Aorta, Abdominal/diagnostic imaging ; Aorta, Abdominal/pathology ; Aorta, Abdominal/surgery ; Aortic Rupture/diagnostic imaging ; Aortic Rupture/etiology ; Aortic Rupture/pathology ; Bleomycin/administration & dosage ; Cisplatin/administration & dosage ; Computed Tomography Angiography ; Etoposide/administration & dosage ; Hemorrhage/diagnostic imaging ; Hemorrhage/etiology ; Humans ; Iliac Vein ; Lymph Node Excision ; Male ; Middle Aged ; Orchiectomy ; Vascular Neoplasms/diagnostic imaging ; Vascular Neoplasms/drug therapy ; Vascular Neoplasms/secondary ; Vascular Neoplasms/surgery ; Vena Cava, Inferior/surgery ; Venous Thrombosis/surgery
SCR Protocol :: BEP protocol
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Electrocoagulation for liver metastases.
Autorzy :: Storman D; Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics, Jagiellonian University Medical College, Krakow, Poland.
Swierz MJ; Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics, Jagiellonian University Medical College, Krakow, Poland.
Riemsma RP; Kleijnen Systematic Reviews Ltd, York, UK.
Wolff R; Kleijnen Systematic Reviews Ltd, York, UK.
Mitus JW; Department of Surgical Oncology, The Maria Sklodowska-Curie Institute, Oncology Center, Krakow Branch; Department of Anatomy, Jagiellonian University Medical College, Krakow, Poland.
Pedziwiatr M; 2nd Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland.
Kleijnen J; School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands.
Bala MM; Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics, Jagiellonian University Medical College, Krakow, Poland.; Pokaż więcej
Źródło :: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 Jan 28; Vol. 1. Cochrane AN: CD009497. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :: Colonic Neoplasms*
Electrocoagulation/*methods
Liver Neoplasms/*secondary
Liver Neoplasms/*surgery
Adult ; Aged ; Allopurinol/administration & dosage ; Cause of Death ; Dimethyl Sulfoxide/administration & dosage ; Electrocoagulation/mortality ; Female ; Humans ; Liver Neoplasms/mortality ; Male ; Middle Aged ; Randomized Controlled Trials as Topic ; Solvents/administration & dosage
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: [Interpretation of the 2020 American society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer].
Autorzy :: Wang JP; Department of Colorectal Surgery, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China.; Pokaż więcej
Źródło :: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery [Zhonghua Wei Chang Wai Ke Za Zhi] 2021 Jan 25; Vol. 24 (1), pp. 27-34.
Typ publikacji :: Journal Article
MeSH Terms :: Proctectomy*
Rectal Neoplasms*/surgery
Rectal Neoplasms*/therapy
Humans ; Lymph Node Excision ; Neoplasms, Multiple Primary/surgery ; Neoplasms, Multiple Primary/therapy ; Practice Guidelines as Topic ; Rectum/surgery ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants.
Autorzy :: Arakawa A; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Ichikawa H; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Kubo T; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Motoi N; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Kumamoto T; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Nakajima M; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Yonemori K; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Noguchi E; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Sunami K; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Shiraishi K; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Kakishima H; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Yoshida H; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Hishiki T; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Kawakubo N; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Kuroda T; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Kiyokawa T; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Yamada K; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Yanaihara N; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Takahashi K; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Okamoto A; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Hirabayashi S; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Hasegawa D; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Manabe A; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Ono K; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Matsuoka M; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Arai Y; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Togashi Y; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Shibata T; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Nishikawa H; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Aoki K; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Yamamoto N; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Kohno T; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.
Ogawa C; From the Departments of Pediatric Oncology (A.A., T. Kumamoto, M.N., C.O.), Laboratory Medicine (T. Kubo, K. Sunami, H.K.), Diagnostic Pathology (N.M., H.Y.), Breast and Medical Oncology (K. Yonemori, E.N.), Pediatric Surgical Oncology (T.H., N.K.), and Experimental Therapeutics (N. Yamamoto), National Cancer Center Hospital, the Departments of Clinical Genomics (H.I., T. Kubo) and Immune Medicine (K.A.), and the Divisions of Genome Biology (K. Shiraishi, T. Kohno), Cancer Genomics (Y.A., T.S.), and Cancer Immunology (Y.T., H.N.), National Cancer Center Research Institute, the Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center (H.I., T. Kubo, T. Kohno), the Children's Cancer Center, National Center for Child Health and Development (T.H.), the Departments of Obstetrics and Gynecology (T. Kuroda, K. Yamada, N. Yanaihara, K. Takahashi, A.O.) and Pathology (T. Kiyokawa), Jikei University School of Medicine, the Departments of Pediatrics (S.H., D.H., A.M.) and Integrated Women's Health (K.O.), St. Luke's International Hospital, and the Department of Pediatrics, Toho University School of Medicine (M.M.), Tokyo, and the Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo (S.H., A.M.) - both in Japan.; Pokaż więcej
Źródło :: The New England journal of medicine [N Engl J Med] 2021 Jan 07; Vol. 384 (1), pp. 42-50.
Typ publikacji :: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Pregnancy Complications, Neoplastic*
Uterine Cervical Neoplasms*
Adenocarcinoma, Mucinous/*etiology
Carcinoma, Neuroendocrine/*etiology
Lung Neoplasms/*etiology
Adenocarcinoma, Mucinous/diagnostic imaging ; Adenocarcinoma, Mucinous/genetics ; Adult ; Carcinoma, Neuroendocrine/diagnostic imaging ; Carcinoma, Neuroendocrine/genetics ; Carcinoma, Squamous Cell/pathology ; Child ; Fatal Outcome ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Infant ; Lung/diagnostic imaging ; Lung/pathology ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Male ; Mothers ; Pregnancy ; Vagina ; Whole Exome Sequencing
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Chapter XX Antiviral Treatment and Cancer Control.
Autorzy :: Shih WL; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
Fang CT; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
Chen PJ; Institute of Clinical Medicine, National Taiwan University, Taipei, Taiwan. .; Pokaż więcej
Źródło :: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer [Recent Results Cancer Res] 2021; Vol. 217, pp. 325-354.
Typ publikacji :: Journal Article
MeSH Terms :: Antiviral Agents*/pharmacology
Antiviral Agents*/therapeutic use
Carcinoma, Hepatocellular*/prevention & control
Carcinoma, Hepatocellular*/virology
Herpesvirus 8, Human*
Liver Neoplasms*/prevention & control
Liver Neoplasms*/virology
Adult ; Herpesvirus 4, Human ; Humans ; Neoplasms/prevention & control ; Neoplasms/virology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
Autorzy :: Goldman S; Division of Hematology, Oncology, Neuro-Oncology, Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Pollack IF; Department of Pediatric Neurosurgery, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jakacki RI; Department of Pediatric Neurosurgery, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania.
Billups CA; Department of Biostatistics, St Jude's Children's Research Hospital, Memphis, Tennessee.
Poussaint TY; Department of Radiology, Boston Children's Hospital, Boston, Massachusetts.; Department of Radiology, Harvard Medical School, Boston, Massachusetts.
Adesina AM; Department of Pathology, Baylor College of Medicine, Houston, Texas.
Panigrahy A; Department of Pediatric Radiology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Parsons DW; Texas Children's Cancer and Hematology Centers, Texas Medical Center, Houston, Texas.
Broniscer A; Department of Radiology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Robinson GW; Division of Neuro-Oncology, St Jude's Children's Research Hospital, Memphis, Tennessee.
Robison NJ; Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California.
Partap S; Department of Neurology, Stanford University School of Medicine, Stanford, California.
Kilburn LB; Department of Hematology and Oncology, Children's National Medical Center, Washington, DC.
Onar-Thomas A; Department of Biostatistics, St Jude's Children's Research Hospital, Memphis, Tennessee.
Dunkel IJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Fouladi M; Department of Hematology and Oncology, Cincinnati Children's Hospital, Cincinnati, Ohio.; Pokaż więcej
Źródło :: Neuro-oncology [Neuro Oncol] 2020 Nov 26; Vol. 22 (11), pp. 1696-1704.
Typ publikacji :: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Brain Neoplasms*/drug therapy
Brain Neoplasms*/radiotherapy
Craniopharyngioma*/drug therapy
Craniopharyngioma*/radiotherapy
Interferon alpha-2/*therapeutic use
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Pituitary Neoplasms/drug therapy ; Pituitary Neoplasms/radiotherapy ; Recombinant Proteins/therapeutic use ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm.
Autorzy :: Tremblay D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States.
Feld J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States.
Dougherty M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States.
Czaplinska T; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States.
Sanchez G; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States.
Kremyanskaya M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States.
Bar-Natan M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States.
Shih AH; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States.
Keyzner A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States.
Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, United States. Electronic address: .; Pokaż więcej
Źródło :: Leukemia research [Leuk Res] 2020 Nov; Vol. 98, pp. 106456. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :: Clinical Trial; Letter
MeSH Terms :: Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/mortality
Neoplasms, Second Primary*/drug therapy
Neoplasms, Second Primary*/mortality
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bridged Bicyclo Compounds, Heterocyclic/administration & dosage ; Bridged Bicyclo Compounds, Heterocyclic/adverse effects ; Disease-Free Survival ; Female ; Hematologic Neoplasms/drug therapy ; Hematologic Neoplasms/mortality ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Sulfonamides/administration & dosage ; Sulfonamides/adverse effects ; Survival Rate
: Raport

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe).
Autorzy :: Aljabery F; Division of Urology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Liedberg F; Department of Urology, Skåne University Hospital, Malmö, Sweden.; Department of Translational Medicine, Lund University, Malmö, Sweden.
Häggström C; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Department of Biobank Research, Umeå University, Umeå, Sweden.
Ströck V; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Hosseini A; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
Gårdmark T; Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden.
Sherif A; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
Jerlström T; Department of Urology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Malmström PU; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Hagberg O; Department of Translational Medicine, Lund University, Malmö, Sweden.
Holmberg L; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; School of Medicine, King's College London, London, UK.; Pokaż więcej
Źródło :: BJU international [BJU Int] 2020 Nov; Vol. 126 (5), pp. 625-632. Date of Electronic Publication: 2020 Aug 31.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/mortality
Urinary Bladder Neoplasms*/therapy
Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/diagnosis ; Neoplasms/epidemiology ; Neoplasms/mortality ; Neoplasms/therapy ; Prognosis ; Sweden ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Neoplasms"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język